Bacterial vaginosis (BV), the leading cause of vaginal discharge, is associated with multiple adverse health outcomes; however, its etiology is unknown. BV treatment is not very effective, thus prevention approaches are needed. Studies investigating the impact of vitamin D on the risk of BV have had mixed findings, including two studies reporting increased risk of recurrent BV for women with higher vitamin D.
Materials and Methods:
Participants were nonpregnant women in a prospective fibroid study of African Americans (ages 23–34 years) from the Detroit area. The exposure was seasonally adjusted annual mean serum 25-hydroxyvitamin D [25(OH)D] at enrollment. The outcome was self-reported doctor-diagnosed BV over ∼20 months between baseline and follow-up. Multivariable-adjusted binomial regression models estimated the risk of BV for a doubling of 25(OH)D and sufficient (≥20 ng/mL) versus deficient (<20 ng/mL) 25(OH)D.
Results:
In total, 1459 women were included. Median 25(OH)D was 15.2 ng/mL and 73% were deficient. Sixteen percent of participants reported BV diagnoses over follow-up, 78% of whom had recurrent BV. In multivariable-adjusted analyses, a doubling of 25(OH)D was associated with an increased, rather than the hypothesized decreased, risk of self-reported BV (risk ratio [RR] 1.22, 95% confidence interval 1.02–1.48). Sufficient women also had a significantly higher, rather than lower, risk of self-reported BV (RR 1.31). Results were robust to sensitivity analyses, and post hoc analyses showed no evidence of reverse causation.
Conclusions:
Overall, our findings do not support vitamin D deficiency as a risk factor for BV in these young, nonpregnant African American women.
Get full access to this article
View all access options for this article.
References
1.
SobelJD. Vaginitis. N Engl J Med, 1997; 337:1896–1903.
2.
KoumansEH, SternbergM, BruceC, et al.The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis, 2007; 34:864–869.
3.
AtashiliJ, PooleC, NdumbePM, AdimoraAA, SmithJS. Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies. AIDS, 2008; 22:1493–1501.
4.
BrotmanRM, KlebanoffMA, NanselTR, et al.Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis, 2010; 202:1907–1915.
5.
CherpesTL, MeynLA, KrohnMA, LurieJG, HillierSL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis, 2003; 37:319–325.
6.
HaggertyCL, TottenPA, TangG, et al.Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex Transm Infect, 2016; 92:441–446.
7.
KlebanoffMA, HillierSL, NugentRP, et al.Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation?. Am J Obstet Gynecol, 2005; 192:470–477.
8.
NelsonDB, HanlonAL, WuG, LiuC, FredricksDN. First trimester levels of BV-associated bacteria and risk of miscarriage among women early in pregnancy. Mater Child Health J, 2015; 19:2682–2687.
9.
BradshawCS, MortonAN, HockingJ, et al.High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis, 2006; 193:1478–1486.
10.
Institute of Medicine. Dietary reference intakes for calcium and Vitamin D. In: RossAC, TaylorCL, YaktineAL, Del ValleHB, eds. Washington (DC): The National Academies Press, 2011:487.
11.
ForrestKY, StuhldreherWL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res, 2011; 31:48–54.
12.
CantornaMT, ZhuY, FroicuM, WittkeA. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr, 2004; 80:1717S–1720S.
13.
TurnerAN, Carr ReeseP, FieldsKS, et al.A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. Am J Obstet Gynecol, 2014; 211:479 e471–479 e413.
14.
MoukayedM, GrantWB. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord, 2017; 18:167–182.
15.
RosenY, DaichJ, SolimanI, BrathwaiteE, ShoenfeldY. Vitamin D and autoimmunity. Scand J Rheumatol, 2016; 45:439–447.
16.
HanYY, FornoE, CeledonJC. Vitamin D insufficiency and asthma in a US nationwide study. J Allergy Clin Immunol Pract, 2017; 5:790–796.
17.
WatkinsRR, LemonovichTL, SalataRA. An update on the association of vitamin D deficiency with common infectious diseases. Can J Physiol Pharmacol, 2015; 93:363–368.
18.
HuangSJ, WangXH, LiuZD, et al.Vitamin D deficiency and the risk of tuberculosis: A meta-analysis. Drug Design Dev Ther, 2017; 11:91–102.
19.
PinzoneMR, Di RosaM, MalaguarneraM, et al.Vitamin D deficiency in HIV infection: An underestimated and undertreated epidemic. Eur Rev Med Pharmacol Sci, 2013; 17:1218–1232.
20.
ColeAM. Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol, 2006; 306:199–230.
21.
HoeE, NathanielszJ, TohZQ, et al.Anti-inflammatory effects of vitamin D on human immune cells in the context of bacterial infection. Nutrients, 2016; 8:806–819.
22.
ChesneyRW. Vitamin D and the magic mountain: The anti-infectious role of the vitamin. J Pediatr, 2010; 156:698–703.
23.
AziziehF, AlyahyaKO, RaghupathyR. Association between levels of vitamin D and inflammatory markers in healthy women. J Inflamm Res, 2016; 9:51–57.
24.
TurnerAN, Carr ReeseP, ChenPL, et al.Serum vitamin D status and bacterial vaginosis prevalence and incidence in Zimbabwean women. Am J Obstet Gynecol, 2016; 215:332 e331–332 e310.
25.
BodnarLM, KrohnMA, SimhanHN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr, 2009; 139:1157–1161.
26.
DavisLM, ChangSC, ManciniJ, NathansonMS, WitterFR, O'BrienKO. Vitamin D insufficiency is prevalent among pregnant African American adolescents. J Pediatr Adolesc Gynecol, 2010; 23:45–52.
27.
DunlopAL, TaylorRN, TangprichaV, FortunatoS, MenonR. Maternal vitamin D, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy. Infect Dis Obstet Gynecol, 2011; 2011:216217.
28.
HenselKJ, RandisTM, GelberSE, RatnerAJ. Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis. Am J Obstet Gynecol, 2011; 204:41 e41–49.
29.
WagnerCL, McNeilR, HamiltonSA, et al.A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol, 2013; 208:137 e131–113.
30.
FrenchAL, AdeyemiOM, AgnielDM, et al.The association of HIV status with bacterial vaginosis and vitamin D in the United States. J Womens Health (Larchmt), 2011; 20:1497–1503.
31.
TaheriM, BaheiraeiA, ForoushaniAR, NikmaneshB, ModarresM. Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: A placebo-controlled randomized clinical trial. Indian J Med Res, 2015; 141:799–806.
32.
KlebanoffMA, TurnerAN. Bacterial vaginosis and season, a proxy for vitamin D status. Sex Transm Dis, 2014; 41:295–299.
33.
BairdDD, HarmonQE, UpsonK, et al.A prospective, ultrasound-based study to evaluate risk factors for uterine fibroid incidence and growth: Methods and results of recruitment. J Womens Health (Larchmt), 2015; 24:907–915.
34.
HarmonQE, UmbachDM, BairdDD. Use of estrogen-containing contraception is associated with increased concentrations of 25-Hydroxy vitamin D. J Clin Endocrinol Metab, 2016; 101:3370–3377.
35.
ErsfeldDL, RaoDS, BodyJJ, et al.Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem, 2004; 37:867–874.
36.
WagnerD, HanwellHE, ViethR. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem, 2009; 42:1549–1556.
37.
JukicAM, UpsonK, HarmonQE, BairdDD. Increasing serum 25-hydroxyvitamin D is associated with reduced odds of long menstrual cycles in a cross-sectional study of African American women. Fertil Steril, 2016; 106:172–179 e172.
38.
SachsMC, ShobenA, LevinGP, et al.Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: The multi-ethnic study of atherosclerosis. Am J Clin Nutr, 2013; 97:1243–1251.
39.
VodstrcilLA, HockingJS, LawM, et al.Hormonal contraception is associated with a reduced risk of bacterial vaginosis: A systematic review and meta-analysis. PLoS One, 2013; 8:e73055.
40.
KlebanoffMA, SchwebkeJR, ZhangJ, NanselTR, YuKF, AndrewsWW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol, 2004; 104:267–272.
41.
NelsonDB, BellamyS, OdiboA, NachamkinI, NessRB, Allen-TaylorL. Vaginal symptoms and bacterial vaginosis (BV): How useful is self-report? Development of a screening tool for predicting BV status. Epidemiol Infect, 2007; 135:1369–1375.
42.
FarrellCJ, MartinS, McWhinneyB, StraubI, WilliamsP, HerrmannM. State-of-the-art vitamin D assays: A comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem, 2012; 58:531–542.
